Skip to main content
PMC home page
Gut logoLink to Gut
. 1989 Jan;30(1):90–96. doi: 10.1136/gut.30.1.90

Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.

K Lenz 1, H Hörtnagl 1, W Druml 1, G Grimm 1, A Laggner 1, B Schneeweisz 1, G Kleinberger 1
PMCID: PMC1378237  PMID: 2646181

Abstract

In nine patients with decompensated alcoholic cirrhosis of the liver and impaired renal function the effect of 8-ornithin vasopressin (ornipressin) on renal function and haemodynamic parameters was studied. Ornipressin was infused at a dose of 6 IU/h over a period of four hours. During ornipressin infusion an improvement of renal function was achieved as indicated by an increase of creatinine clearance (76 (15)%; p less than 0.01), urine volume (108 (29)%; p less than 0.05) and sodium excretion (168 (30)%; p less than 0.05). The hyperdynamic circulation of hepatic failure, as characterised by increased cardiac index and heart rate as well as decreased systemic vascular resistance was reversed to a nearly normal circulatory state during ornipressin infusion. The raised noradrenaline plasma concentration (1.74 (0.31) ng/ml) and plasma renin activity (13.5 (3.9) ng/ml/h) were lowered during ornipressin infusion to 0.87 (0.21) ng/ml and 5.9 (2.1) ng/ml/h, respectively (p less than 0.01). The efficacy of a vasoconstrictor agent in reverting a hyperdynamic state and improving renal function provides evidence for the substantial role of accumulation of vasodilator substances and subsequent activation of sympathetic nervous system and renin-angiotensin-axis in the pathogenesis of renal dysfunction in hepatic failure. Values are expressed as mean (SE).

Full text

PDF
94

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arendt R. M., Gerbes A. L., Ritter D., Stangl E., Bach P., Zähringer J. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. J Hypertens Suppl. 1986 Jun;4(2):S131–S135. [PubMed] [Google Scholar]
  2. Arroyo V., Planas R., Gaya J., Deulofeu R., Rimola A., Pérez-Ayuso R. M., Rivera F., Rodés J. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest. 1983 Jun;13(3):271–278. doi: 10.1111/j.1365-2362.1983.tb00100.x. [DOI] [PubMed] [Google Scholar]
  3. BARRATT-BOYES B. G., WOOD E. H. Cardiac output and related measurements and pressure values in the right heart and associated vessels, together with an analysis of the hemo-dynamic response to the inhalation of high oxygen mixtures in healthy subjects. J Lab Clin Med. 1958 Jan;51(1):72–90. [PubMed] [Google Scholar]
  4. Bell-Reuss E., Trevino D. L., Gottschalk C. W. Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest. 1976 Apr;57(4):1104–1107. doi: 10.1172/JCI108355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Better O. S., Schrier R. W. Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int. 1983 Feb;23(2):303–311. doi: 10.1038/ki.1983.20. [DOI] [PubMed] [Google Scholar]
  6. Bichet D. G., Groves B. M., Schrier R. W. Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients. Kidney Int. 1983 Dec;24(6):788–794. doi: 10.1038/ki.1983.229. [DOI] [PubMed] [Google Scholar]
  7. Bichet D. G., Van Putten V. J., Schrier R. W. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med. 1982 Dec 16;307(25):1552–1557. doi: 10.1056/NEJM198212163072504. [DOI] [PubMed] [Google Scholar]
  8. Burghardt W., Wernze H., Diehl K. L. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis. Klin Wochenschr. 1986;64 (Suppl 6):103–107. [PubMed] [Google Scholar]
  9. Cohn J. N., Tristani F. E., Khatri I. M. Systemic vasoconstrictor and renal vasodilator effects of PLV-2 (octapressin) in man. Circulation. 1968 Jul;38(1):151–157. doi: 10.1161/01.cir.38.1.151. [DOI] [PubMed] [Google Scholar]
  10. Deen W. M., Robertson C. R., Brenner B. M. Glomerular ultrafiltration. Fed Proc. 1974 Jan;33(1):14–20. [PubMed] [Google Scholar]
  11. DiBona G. F. Renal neural activity in hepatorenal syndrome. Kidney Int. 1984 May;25(5):841–853. doi: 10.1038/ki.1984.99. [DOI] [PubMed] [Google Scholar]
  12. Epstein M., Berk D. P., Hollenberg N. K., Adams D. F., Chalmers T. C., Abrams H. L., Merrill J. P. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med. 1970 Aug;49(2):175–185. doi: 10.1016/s0002-9343(70)80073-0. [DOI] [PubMed] [Google Scholar]
  13. Fernández-Cruz A., Marco J., Cuadrado L. M., Gutkowska J., Rodríguez-Puyol D., Caramelo C., López-Novoa J. M. Plasma levels of atrial natriuretic peptide in cirrhotic patients. Lancet. 1985 Dec 21;2(8469-70):1439–1440. doi: 10.1016/s0140-6736(85)92618-2. [DOI] [PubMed] [Google Scholar]
  14. Fischer J. E., Baldessarini R. J. False neurotransmitters and hepatic failure. Lancet. 1971 Jul 10;2(7715):75–80. doi: 10.1016/s0140-6736(71)92048-4. [DOI] [PubMed] [Google Scholar]
  15. GORNEL D. L., LANCESTREMERE R. G., PAPPER S., LOWENSTEIN L. M. Acute changes in renal excretion of water and solute in patients with Laennec's cirrhosis, induced by the administration of the pressor amine, metaraminol. J Clin Invest. 1962 Mar;41:594–603. doi: 10.1172/JCI104514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gentilini P., Laffi G., Buzzelli G., Stefani P., Scarpelli P., Paladini S., Smorlesi C., La Villa G., Forti G. Functional renal alterations in chronic liver diseases. Digestion. 1980;20(2):73–78. doi: 10.1159/000198421. [DOI] [PubMed] [Google Scholar]
  17. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  18. Hörtnagl H., Lochs H., Kleinberger G., Hackl J. M., Hammerle A. F., Binder H., Wewalka F. Plasma catecholamines in hepatic coma and liver cirrhosis: role of octopamine. Klin Wochenschr. 1981 Oct 15;59(20):1159–1164. doi: 10.1007/BF01746264. [DOI] [PubMed] [Google Scholar]
  19. Hörtnagl H., Magometschnigg D., Prager J. Hyperkinetic heart syndrome: the role of the sympathetic nervous system. Cardiology. 1982;69(2):74–83. doi: 10.1159/000173487. [DOI] [PubMed] [Google Scholar]
  20. Hörtnagl H., Singer E. A., Lenz K., Kleinberger G., Lochs H. Substance P is markedly increased in plasma of patients with hepatic coma. Lancet. 1984 Mar 3;1(8375):480–483. doi: 10.1016/s0140-6736(84)92851-4. [DOI] [PubMed] [Google Scholar]
  21. KONTOS H. A., SHAPIRO W., MAUCK H. P., PATTERSON J. L., Jr GENERAL AND REGIONAL CIRCULATORY ALTERATIONS IN CIRRHOSIS OF THE LIVER. Am J Med. 1964 Oct;37:526–535. doi: 10.1016/0002-9343(64)90066-x. [DOI] [PubMed] [Google Scholar]
  22. Kew M. C., Varma R. R., Sampson D. J., Sherlock S. The effect of octapressin on renal and intrarenal blood flow in cirrhosis of the liver. Gut. 1972 Apr;13(4):293–296. doi: 10.1136/gut.13.4.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koppel M. H., Coburn J. W., Mims M. M., Goldstein H., Boyle J. D., Rubini M. E. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med. 1969 Jun 19;280(25):1367–1371. doi: 10.1056/NEJM196906192802501. [DOI] [PubMed] [Google Scholar]
  24. LANCESTREMERE R. G., KLINGLER E. L., Jr, FRISCH E., PAPPER S. Simultaneous determination of cardiac output and renal function in patients with Laennec's cirrhosis during the administration of the pressor amine, metaraminol. J Lab Clin Med. 1963 May;61:820–825. [PubMed] [Google Scholar]
  25. Lenz K., Druml W., Kleinberger G., Hörtnagl H., Laggner A., Schneeweiss B., Deutsch E. Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis. Gut. 1985 Dec;26(12):1385–1386. doi: 10.1136/gut.26.12.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lenz K., Hörtnagl H., Magometschnigg D., Kleinberger G., Druml W., Laggner A. Function of the autonomic nervous system in patients with hepatic encephalopathy. Hepatology. 1985 Sep-Oct;5(5):831–836. doi: 10.1002/hep.1840050521. [DOI] [PubMed] [Google Scholar]
  27. Levy M., Allotey J. B. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med. 1978 Oct;92(4):560–569. [PubMed] [Google Scholar]
  28. MURRAY J. F., DAWSON A. M., SHERLOCK S. Circulatory changes in chronic liver disease. Am J Med. 1958 Mar;24(3):358–367. doi: 10.1016/0002-9343(58)90322-x. [DOI] [PubMed] [Google Scholar]
  29. Nicholls K. M., Shapiro M. D., Van Putten V. J., Kluge R., Chung H. M., Bichet D. G., Schrier R. W. Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ Res. 1985 Mar;56(3):457–461. doi: 10.1161/01.res.56.3.457. [DOI] [PubMed] [Google Scholar]
  30. PAPPER S., BELSKY J. L., BLEIFER K. H. Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features. Ann Intern Med. 1959 Oct;51:759–773. doi: 10.7326/0003-4819-51-4-759. [DOI] [PubMed] [Google Scholar]
  31. Pérez-Ayuso R. M., Arroyo V., Camps J., Rimola A., Costa J., Gaya J., Rivera F., Rodés J. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics. Hepatology. 1984 Mar-Apr;4(2):247–252. doi: 10.1002/hep.1840040213. [DOI] [PubMed] [Google Scholar]
  32. Ring-Larsen H., Hesse B., Henriksen J. H., Christensen N. J. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release. Hepatology. 1982 May-Jun;2(3):304–310. doi: 10.1002/hep.1840020303. [DOI] [PubMed] [Google Scholar]
  33. Rosoff L., Jr, Williams J., Moult P., Williams H., Sherlock S. Renal hemodynamics and the renin--angiotensin system in cirrhosis: relationship to sodium retention. Dig Dis Sci. 1979 Jan;24(1):25–32. doi: 10.1007/BF01297234. [DOI] [PubMed] [Google Scholar]
  34. SHEAR L., KLEINERMAN J., GABUZDA G. J. RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS. Am J Med. 1965 Aug;39:184–198. doi: 10.1016/0002-9343(65)90041-0. [DOI] [PubMed] [Google Scholar]
  35. Sellars L., Shore A. C., Wilkinson R., James O. F., Robson V. Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease. Eur J Clin Invest. 1981 Aug;11(4):299–304. doi: 10.1111/j.1365-2362.1981.tb02120.x. [DOI] [PubMed] [Google Scholar]
  36. Shapiro M. D., Nicholls K. M., Groves B. M., Kluge R., Chung H. M., Bichet D. G., Schrier R. W. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int. 1985 Aug;28(2):206–211. doi: 10.1038/ki.1985.142. [DOI] [PubMed] [Google Scholar]
  37. Siegel J. H., Goldwyn R. M., Farrell E. J., Gallin P., Friedman H. P. Hyperdynamic states and the physiologic determinants of survival in patients with cirrhosis and portal hypertension. Arch Surg. 1974 Mar;108(3):282–292. doi: 10.1001/archsurg.1974.01350270016004. [DOI] [PubMed] [Google Scholar]
  38. Solis-Herruzo J. A., Duran A., Favela V., Castellano G., Madrid J. L., Muñoz-Yagüe M. T., Morillas J. D., Estenoz J. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol. 1987 Oct;5(2):167–173. doi: 10.1016/s0168-8278(87)80569-x. [DOI] [PubMed] [Google Scholar]
  39. Tristani F. E., Cohn J. N. Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion. J Clin Invest. 1967 Dec;46(12):1894–1906. doi: 10.1172/JCI105679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wernze H., Spech H. J., Müller G. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Klin Wochenschr. 1978 Apr 15;56(8):389–397. doi: 10.1007/BF01477293. [DOI] [PubMed] [Google Scholar]
  41. Wong P. Y., Talamo R. C., Williams G. H. Kallikrein-kinin and renin-angiotensin systems in functional renal failure of cirrhosis of the liver. Gastroenterology. 1977 Nov;73(5):1114–1118. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES